Published in Am J Public Health on October 01, 2009
Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics (2010) 1.57
Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sex Health (2010) 0.97
Predictors of three dose on-time compliance with HPV4 vaccination in a disadvantaged, underserved, safety net population in the US Midwest. PLoS One (2013) 0.87
Addressing adolescent immunization disparities: a retrospective analysis of school-based health center immunization delivery. Am J Public Health (2010) 0.81
Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness Analysis. J Gen Intern Med (2016) 0.81
Adolescent and adult risk-taking in virtual social contexts. Front Psychol (2014) 0.78
In a safety net population HPV4 vaccine adherence worsens as BMI increases. PLoS One (2014) 0.77
Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review. BMC Public Health (2016) 0.77
Quantifying clinical HPV4 dose inefficiencies in a safety net population. PLoS One (2013) 0.77
Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants. J Pharm Sci (2015) 0.76
Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States. Ther Adv Vaccines (2017) 0.75
Shortened Intervals during Heterologous Boosting Preserve Memory CD8 T Cell Function but Compromise Longevity. J Immunol (2016) 0.75
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20
Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep (1991) 3.46
National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med (2007) 2.83
Health outcomes among Hispanic subgroups: data from the National Health Interview Survey, 1992-95. Adv Data (2000) 2.70
Vaccination coverage among adolescents aged 13-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep (2008) 2.31
Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep (1996) 2.09
Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep (1996) 1.70
Predictors of time to completion of the hepatitis B vaccination series among adolescents. J Adolesc Health (1999) 1.67
Hepatitis B vaccination coverage among adults--United States, 2004. MMWR Morb Mortal Wkly Rep (2006) 1.59
Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep (1982) 1.50
The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf (2002) 1.39
Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther (2001) 1.35
Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis (1988) 1.28
Challenges to vaccinating adolescents: vaccine implementation issues. Pediatr Infect Dis J (2005) 1.27
Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis (1995) 1.25
Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. Am J Med (1989) 1.22
Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team. Am J Epidemiol (1999) 1.19
Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. J Infect (1986) 1.13
Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend (2007) 1.05
Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatr Infect Dis J (1993) 1.03
Parental knowledge, attitudes, and practices associated with not receiving hepatitis A vaccine in a demonstration project in Butte County, California. Pediatrics (2003) 0.99
Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children. J Infect Dis (1995) 0.98
Hepatitis A and B vaccination in a sexually transmitted disease clinic for men who have sex with men. Sex Transm Dis (2003) 0.93
Hepatitis A 2004 vaccination in children: methods and findings of a survey in two states. Am J Prev Med (2007) 0.92
Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre. Sex Health (2007) 0.91
Hepatitis B vaccination among adolescents in 3 large health maintenance organizations. Pediatrics (2002) 0.90
A comparison of two commercial recombinant vaccines for hepatitis B in adolescents. Vaccine (2000) 0.87
Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group. Vaccine (1995) 0.86
Hepatitis A vaccine uptake in San Diego County: Hispanic children are better immunized. Arch Pediatr Adolesc Med (2005) 0.86
Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults. J Infect Dis (1995) 0.86
Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults. Vaccine (1999) 0.84
Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers. J Gastroenterol Hepatol (1993) 0.78
A managed care organization's attempt to increase influenza and pneumococcal immunizations for older adults in an acute care setting. J Am Geriatr Soc (1999) 0.78
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79
Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med (2004) 11.52
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med (2006) 9.73
Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol (2004) 8.97
Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90
Systolic and diastolic heart failure in the community. JAMA (2006) 5.99
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis (2007) 5.91
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16
Urologic diseases in America project: benign prostatic hyperplasia. J Urol (2005) 4.09
Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med (2010) 3.83
Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol (2002) 3.68
Azithromycin for the secondary prevention of coronary events. N Engl J Med (2005) 3.42
Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation (2005) 3.34
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis (2009) 3.26
Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet (2008) 3.23
Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care (2008) 3.08
The association between statin use and the diagnosis of prostate cancer in a population based cohort. J Urol (2010) 3.08
Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation (2010) 3.07
The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis (2004) 2.96
Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med (2002) 2.87
Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA (2011) 2.86
Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr (2013) 2.86
Redefinition of myocardial infarction: prospective evaluation in the community. Circulation (2006) 2.76
The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum (2005) 2.74
Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis (2005) 2.74
Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc (2013) 2.72
Agreement between patient reports of cardiovascular disease and patient medical records. Mayo Clin Proc (2005) 2.71
Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol (2005) 2.69
Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol (2003) 2.62
Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation (2005) 2.61
Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res (2007) 2.56
Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J (2012) 2.55
Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA (2011) 2.54
Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol (2004) 2.52
How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med (2002) 2.51
Prevalence of extreme obesity in a multiethnic cohort of children and adolescents. J Pediatr (2010) 2.46
Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years. Vaccine (2012) 2.43
Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol (2010) 2.42
Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med (2010) 2.40
Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics (2010) 2.39
Urologic diseases in america project: benign prostatic hyperplasia. J Urol (2008) 2.38
Teaching and learning responsible research conduct: influences of prior experiences on acceptance of new ideas. Account Res (2008) 2.38
Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc (2006) 2.37
Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr (2007) 2.36
Coronary heart disease death and sudden cardiac death: a 20-year population-based study. Am J Epidemiol (2003) 2.34
Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA (2010) 2.30
Secular trends in deaths from cardiovascular diseases: a 25-year community study. Circulation (2006) 2.24
Influenza- and RSV-associated hospitalizations among adults. Vaccine (2006) 2.23
Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med (2013) 2.18
Electronic medical records for clinical research: application to the identification of heart failure. Am J Manag Care (2007) 2.18
Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep (2014) 2.15
Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med (2006) 2.09
Coronary disease surveillance in Olmsted County objectives and methodology. J Clin Epidemiol (2002) 2.06
A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer. Mayo Clin Proc (2002) 2.04
Population-based prevalence of repeated group A beta-hemolytic streptococcal pharyngitis episodes. Mayo Clin Proc (2006) 2.03
Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine. Vaccine (2011) 2.03
Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health (2009) 2.03
Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol (2003) 2.03
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res (2005) 2.02
Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. MMWR Morb Mortal Wkly Rep (2015) 2.01
Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch Intern Med (2007) 2.00
Scores for post-myocardial infarction risk stratification in the community. Circulation (2002) 1.98
A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc (2009) 1.98
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol (2006) 1.98
The incidence of autism in Olmsted County, Minnesota, 1976-1997: results from a population-based study. Arch Pediatr Adolesc Med (2005) 1.97
Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc (2009) 1.96
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis (2006) 1.96
Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics (2008) 1.96
Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev (2007) 1.94
Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort. Am J Epidemiol (2009) 1.92
Temporal trends in the incidence of coronary disease. Am J Med (2004) 1.86
Math learning disorder: incidence in a population-based birth cohort, 1976-82, Rochester, Minn. Ambul Pediatr (2005) 1.83
Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2012) 1.78
Heart failure after myocardial infarction: a review. Am J Med (2002) 1.76
Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med (2006) 1.75
Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine (2008) 1.74
A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr (2013) 1.74
Seasonality and daily weather conditions in relation to myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, 1979 to 2002. J Am Coll Cardiol (2006) 1.73
Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation (2007) 1.72
New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol (2009) 1.72
Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine (2009) 1.71
Asthma and farm exposures in a cohort of rural Iowa children. Environ Health Perspect (2005) 1.71
The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol (2004) 1.70
Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine (2011) 1.70
Is benign prostatic hyperplasia a risk factor for chronic renal failure? J Urol (2005) 1.70
Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab (2003) 1.69
Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation (2004) 1.67
The essential role of generalists in health care systems. Ann Intern Med (2005) 1.65
Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol (2002) 1.64
Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr (2006) 1.63
Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics (2008) 1.63